SAR438544 - Clinical & Exploratory Pharmacology
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2016
At a glance
- Drugs SAR 438544 (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 29 Jul 2016 Status changed from not yet recruiting to withdrawn prior to enrolment since the company has decided not to pursue the development of SAR438544 in diabetes, according to a Sanofi media release.
- 20 Apr 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016.
- 20 Apr 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Nov 2016.